Menu
GWAS Study

A Multi-Ancestry Genome Wide Association Study and Evaluation of Polygenic Scores of LDL-C levels.

Ismail Umlai UK, Toor SM, Al-Sarraj YA et al.

39909172 PubMed ID
GWAS Study Type
13701 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

IU
Ismail Umlai UK
TS
Toor SM
AY
Al-Sarraj YA
MS
Mohammed S
AH
Al Hail MSH
UE
Ullah E
KK
Kunji K
EA
El-Menyar A
GM
Gomaa M
JA
Jayyousi A
SM
Saad M
QN
Qureshi N
AS
Al Suwaidi JM
AO
Albagha OME
Chapter II

Abstract

Summary of the research findings

The genetic determinants of low-density lipoprotein cholesterol (LDL-C) levels in blood have been predominantly explored in European populations and remain poorly understood in Middle Eastern populations. We investigated the genetic architecture of LDL-C variation in Qatar by conducting a genome-wide association study (GWAS) on serum LDL-C levels using whole genome sequencing data of 13,701 individuals (discovery; n = 5,939, replication; n = 7,762) from the population-based Qatar Biobank (QBB) cohort. We replicated 168 previously reported loci from the largest LDL-C GWAS by the Global Lipids Genetics Consortium (GLGC), with high correlation in allele frequencies (R2 = 0.77) and moderate correlation in effect sizes (Beta; R2 = 0.53). We also performed a multi-ancestry meta-analysis with the GLGC study using MR-MEGA (Meta-Regression of Multi-Ethnic Genetic Association) and identified one novel LDL-C-associated locus; rs10939663 (SLC2A9; genomic control-corrected P = 1.25 × 10-8). Lastly, we developed Qatari-specific polygenic score (PGS) panels and tested their performance against PGS derived from other ancestries. The multi-ancestry-derived PGS (PGS000888) performed best at predicting LDL-C levels, whilst the Qatari-derived PGS showed comparable performance. Overall, we report a novel gene associated with LDL-C levels, which may be explored further to decipher its potential role in the etiopathogenesis of cardiovascular diseases. Our findings also highlight the importance of population-based genetics in developing PGS for clinical utilization.

5,939 Qatari ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

13701
Total Participants
GWAS
Study Type
Yes
Replicated
7,762 Qatari ancestry individuals
Replication Participants
Greater Middle Eastern (Middle Eastern, North African or Persian), African unspecified, East Asian, European, Hispanic or Latin American, South Asian
Ancestry
Qatar
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.